arXiv subjects

Simon Ducharme

Publications and source records attributed to Simon Ducharme.

4 recordsLinked to original sources

arXiv2026

Asymptotic Compression of Interactive Quantum Communication using Type-Constrained de Finetti Reduction

For many information processing tasks, de Finetti-style theorems can often simplify the analysis in worst-case input scenarios for which the task exhibits some permutation-invariance symmetry, as they can allow for a reduction from an analysis on worst-case inputs to that of i.i.d. inputs. If further information is available on the inputs, it might be advantageous to reflect this information in the de Finetti reduction. In our work, we focus on a form of such constraint, based on the type of the input. This allows us to obtain a conceptually simple proof of a new de Finetti reduction for classical probability distributions, derived from elementary properties from the method of types. We apply our constrained de Finetti reduction to the compression of quantum interactive communication protocols with classical inputs, and prove that the prior-free quantum information cost equals the worst-case input amortized quantum communication cost.

quant-ph↗

arXiv2024

Identifying latent disease factors differently expressed in patient subgroups using group factor analysis

In this study, we propose a novel approach to uncover subgroup-specific and subgroup-common latent factors addressing the challenges posed by the heterogeneity of neurological and mental disorders, which hinder disease understanding, treatment development, and outcome prediction. The proposed approach, sparse Group Factor Analysis (GFA) with regularised horseshoe priors, was implemented with probabilistic programming and can uncover associations (or latent factors) among multiple data modalities differentially expressed in sample subgroups. Synthetic data experiments showed the robustness of our sparse GFA by correctly inferring latent factors and model parameters. When applied to the Genetic Frontotemporal Dementia Initiative (GENFI) dataset, which comprises patients with frontotemporal dementia (FTD) with genetically defined subgroups, the sparse GFA identified latent disease factors differentially expressed across the subgroups, distinguishing between "subgroup-specific" latent factors within homogeneous groups and "subgroup common" latent factors shared across subgroups. The latent disease factors captured associations between brain structure and non-imaging variables (i.e., questionnaires assessing behaviour and disease severity) across the different genetic subgroups, offering insights into disease profiles. Importantly, two latent factors were more pronounced in the two more homogeneous FTD patient subgroups (progranulin (GRN) and microtubule-associated protein tau (MAPT) mutation), showcasing the method's ability to reveal subgroup-specific characteristics. These findings underscore the potential of sparse GFA for integrating multiple data modalities and identifying interpretable latent disease factors that can improve the characterization and stratification of patients with neurological and mental health disorders.

stat.ML↗

arXiv2021

Ventricle features as reliable differentiators between the bvFTD and other dementias

INTRODUCTION: Lateral ventricles are reliable and sensitive indicators of brain atrophy and disease progression in behavioral variant frontotemporal dementia (bvFTD). We aimed to investigate whether an automated tool using ventricular features could improve diagnostic accuracy in bvFTD across neurodegenerative diseases. METHODS: Using 678 subjects (2750 timepoints), differences in ventricular features were assessed between bvFTD, normal controls and other dementia cohorts. RESULTS: Ventricular antero-posterior ratio (APR) was the only feature that was significantly different and increased faster in bvFTD compared to all other cohorts. We achieved a 10-fold cross-validation accuracy of 80% (77% sensitivity, 82% specificity) in differentiating bvFTD from all other cohorts with ventricular features, and 76% accuracy using only the single APR feature. DISCUSSION: APR could be a useful and easy-to-implement feature to aid bvFTD diagnosis. We have made our ventricle feature estimation and bvFTD diagnostic tool publicly available, allowing application of our model in other studies.

q-bio.NC↗

arXiv2021

Automatic prediction of cognitive and functional decline can significantly decrease the number of subjects required for clinical trials in early Alzheimer's disease

INTRODUCTION: Heterogeneity in the progression of Alzheimer's disease makes it challenging to predict the rate of cognitive and functional decline for individual patients. Tools for short-term prediction could help enrich clinical trial designs and focus prevention strategies on the most at-risk patients. METHOD: We built a prognostic model using baseline cognitive scores and MRI-based features to determine which subjects with mild cognitive impairment remained stable and which functionally declined (measured by a two-point increase in CDR-SB) over 2 and 3-year follow-up periods, periods typical of the length of clinical trials. RESULTS: Combining both sets of features yields 77% accuracy (81% sensitivity and 75% specificity) to predict cognitive decline at 2 years (74% accuracy at 3 years with 75% sensitivity and 73% specificity). Using this tool to select trial participants yields a 3.8-fold decrease in the required sample size for a 2-year study (2.8-fold decrease for a 3-year study) for a hypothesized 25% treatment effect to reduce cognitive decline. DISCUSSION: This cohort enrichment tool could accelerate treatment development by increasing power in clinical trials.

q-bio.QM↗